Jiangsu Vcare Pharmatech Co., Ltd. Selected as National-Level Specialized, Refined, Unique, and Innovative "Little Giant" Enterprises
Published Time:
2024-09-09 17:47
Source:
Recently, the Ministry of Industry and Information Technology (MIIT) announced the sixth batch of National-Level Specialized, Refined, Unique, and Innovative "Little Giant" Enterprises, andJiangsu Vcare Pharmatech Co., Ltd.(Jiangsu Vcare) was successfully selected. Thisnational-levelhonor fully demonstrates that under its "dual-core business model," Jiangsu Vcare's scientific research capabilities, independent innovation capacity, market leadership, and future development potential have received official high recognition.
The National-Level Specialized, Refined, Unique, and Innovative "Little Giant" Enterprises honor is specifically established to encourage small and medium-sized enterprises to achieve development in four aspects: specialized operations, refined output, unique processes, and novel products. It aims to cultivate a group of "pioneer" enterprises focused on niche markets with strong innovation capabilities, high market share, mastery of key core technologies, and excellent quality and efficiency, thereby strengthening the real economy—particularly manufacturing—and enhancing the stability and competitiveness of industrial and supply chains.
Since its establishment, Jiangsu Vcare has been committed to pharmaceutical R&D and innovation, adhering to the "Specialized, Refined, Unique, Innovative" development path, and building a full-chain chemical drug R&D service technology platform. From front-end research, the company has constructed integrated drug R&D platforms including AI molecular generation, drug screening, crystal/salt form selection, and novel drug formulation, establishing core innovation capabilities in early-stage product development. Back-end development further incorporates advanced manufacturing technology platforms such as synthetic biology, enzyme catalysis engineering, and continuous flow engineering, supplemented by preparation/separation technologies and multi-chiral drug development strategies, building robust technical barriers for industrialization. In 2024, the company's revenue will exceed RMB 400 million.
Jiangsu Vcare will continue to uphold its core values of"The better Care, The better Medicines", strengthen its core competitiveness and technological innovation capabilities, and contribute to Chinese pharmaceutical innovation through scientific, conceptual, and management innovation, thereby supporting the "Healthy China" initiative.
Related News
27
2017
/
03
Vice Chairman of Political Consultative Conference of Wenzhou Ouhai District Visited Jiangsu Vcare
The delegation of Political Consultative Conference of Wenzhou Ouhai District, accompanied by vice chairman of Political Consultative Conference of Pukou Economic Development Zone visited Jiangsu Vcare Pharmaceutical Technology Co., Ltd. on the afternoon of March 27, 2017. Yongqiang Liu, the general manager of Jiangsu Vcare received the delegation. Mr. Liu introduced the company's development history and R&D progress. He focused on the progress of phase II clinical trials and the future market prospect of innovative drug Vicagrel. The delegation highly recognized Vcare's advanced equipment and facilities, harmonious human environment and comprehensive research and development capabilities.
View Details
14
2017
/
03
Jiangsu Vcare Held “Firefighting and First Aid” Training
Jiangsu Vcare invited Lei Wang, a special instructor of Nanjing Anqu Fire Education Center to give a “Firefighting and First Aid” course to new employees on March 14, 2017 and 26 new employees participated in the training. Mr. Wang collected a large number of fire cases and carefully analyzed the causes of these fires. He taught everyone how to deal with fires. His explanations made everyone fully aware of the importance and urgency of fire safety. At the same time, everyone had a better understanding of various fire extinguishers and their instructions.
View Details
Company Address:
No. 136, Huakang Road, Jiangbei New Area, Nanjing, P. R. China
Subsidiary NJVcare Website：
Scan to see
Copyright © JIANGSU VCARE PHARMATECH CO.,LTD.
Powerby：www.300.cn nanjing.300.cn